Full Name
Go Mei Lin
Variants
Mei, L.
Mei Lin, G.
Go M.-L.
Go, M.-L.
Go, M.I.
Go, M.L.
Mei, L.G.
Go, Mei Lin
Mei Lin Go
Go, M.
 
Main Affiliation
 
Faculty
 
Email
phagoml@nus.edu.sg
 

Publications

Results 61-80 of 106 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
61Mar-2003Interaction of the antimalarial agents halofantrine and lumefantrine with lipid bilayersGo, M.-L. ; Li, Q.-T.
210-Oct-2006Intracellular drug delivery by sulfatide-mediated liposomes to gliomasShao, K.; Hou, Q.; Duan Wei ; Go Mei Lin ; Wong, K.P.; Li Qiu-Tian 
3Jan-2004Investigation of Molecular Interactions between Paclitaxel and DPPC by Langmuir Film Balance and Differential Scanning CalorimetryZhao, L. ; Feng, S.-S. ; Go, M.L. 
41-Apr-1999M3/M1-selective antimuscarinic tropinyl and piperidinyl estersXu, R.; Sim, M.-K.; Go, M.-L. 
51-Feb-2011Methoxylation of resveratrol: Effects on induction of NAD(P)H Quinone-oxidoreductase 1 (NQO1) activity and growth inhibitory propertiesZhang, W.; Go, M.L. 
62-Sep-2008Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analoguesHan, Y. ; Riwanto, M.; Go, M.-L. ; Rachel Ee, P.L. 
71-Feb-2003Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: Lime, lemon, grapefruit, and pummeloXu, J.; Go, M.L. ; Lim, L.-Y. 
81994Molecular geometry and physicochemical characteristics of selected anilinoquinolines, indolo[3,2-c]quinolines and tetrahydroindolo[3,2- d]benzazepinesKoh, H.-L. ; Go, M.-L. ; Ngiam, T.-L. 
9Jul-2003Novel antiplasmodial agentsGo, M.-L. 
103-Oct-2005Novel neuroprotective effects with O-benzyl derivative of pralidoxime in soman-intoxicated rodentsLoke, W.-K.; Sim, M.-K.; Go, M.-L. 
1110-May-2002O-Substituted derivatives of pralidoxime: Muscarinic properties and protection against soman effects in ratsLoke, W.-K.; Sim, M.-K.; Go, M.-L. 
121993Pharmacological activity and structure-activity relationship of (±)- erythro-mefloquine and related compounds on the isolated mouse phrenic nerve diaphragm preparationGo, M.-L. ; Lee, H.-S.; Ngiam, T.-L. 
13Jul-2006Plasmepsin II inhibitory activity of alkoxylated and hydroxylated chalconesSriwilaijaroen, N.; Liu, M.; Go, M.-L. ; Wilairat, P.
14Jul-2009Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of DocetaxelFeng, S.-S. ; Mei, L. ; Anitha, P.; Gan, C.W.; Zhou, W.
1515-May-2020Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition.Li, Ming; Phua, Zheng Yen; Xi, Yu; Xu, Zhujun ; Nyantakyi, Samuel Agyei; Li, Wei; Jackson, Mary C; Wong, Ming Wah ; Lam, Yulin ; Chng, Shu-Sin ; Go, Mei-Lin ; Dick, Thomas 
1622-Feb-2023PROTAC Antibiotics: The Time is NowJickky Palmae Sarathy ; Courtney C Aldrich; Mei-Lin Go ; Thomas Dick 
1723-Feb-2011Quantification of trans -3,4,5,4′-tetramethoxystilbene in rat plasma by HPLC: Application to pharmacokinetic studyLin, H.-S. ; Zhang, W.; Go, M.L. ; Tringali, C.; Spatafora, C.; Ho, P.C. 
1815-Feb-2007Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferaseLeow, J.-L.; Baron, R.; Casey, P.J.; Go, M.-L. 
19Jun-2007Quinone reductase induction activity of methoxylated analogues of resveratrolZhang, W.; Go, M.L. 
202002Quinuclidinone O-alkynyloximes with muscarinic agonist activitySomanadhan, B.; Loke, W.-K.; Sim, M.-K.; Go, M.-L.